Nonsteroidal Anti-Inflammatory Drugs in Viral Infections Disease, Specially COVID-19
- PMID: 36926440
- PMCID: PMC10012024
- DOI: 10.4103/abr.abr_148_21
Nonsteroidal Anti-Inflammatory Drugs in Viral Infections Disease, Specially COVID-19
Abstract
During the current SARS-CoV-2 (COVID-19) pandemic, some reports were presented based on those nonsteroidal anti-inflammatory drugs (NSAIDs) and corticosteroids may exacerbate symptoms in COVID-19 patients. According to this, we aimed to collate information available in published articles to identify any evidence behind these statements with the aim of helping clinicians on how best to treat patients. We could not find published conclusive evidence for or against the use of NSAIDs in COVID-19 patients. Meanwhile, there appeared to be some evidence that corticosteroids may be beneficial if utilized in the early acute phase of infection, however, conflicting WHO (World Health Organization) evidence surrounding corticosteroid use in certain viral infections means this evidence is not conclusive. Given the current availability of literature, caution should be exercised until further evidence emerges surrounding the use of NSAIDs and corticosteroids in COVID-19 patients. However, the availability of reliable information for clinicians and patients is paramount.
Keywords: COVID-19; Corticosteroid; SARS-CoV-2; nonsteroidal anti-inflammatory drugs.
Copyright: © 2023 Advanced Biomedical Research.
Conflict of interest statement
There are no conflicts of interest.
Similar articles
-
COVID-19 and treatment with NSAIDs and corticosteroids: should we be limiting their use in the clinical setting?Ecancermedicalscience. 2020 Mar 30;14:1023. doi: 10.3332/ecancer.2020.1023. eCollection 2020. Ecancermedicalscience. 2020. PMID: 32256706 Free PMC article.
-
Nonsteroidal anti-inflammatory drugs (NSAIDs) consideration by dermatologists during the COVID19 pandemic.J Dermatolog Treat. 2022 Mar;33(2):1134-1135. doi: 10.1080/09546634.2020.1800580. Epub 2020 Aug 4. J Dermatolog Treat. 2022. PMID: 32723104
-
Efficacy and safety profile of corticosteroids and non-steroidal anti-inflammatory drugs in COVID-19 management: A narrative review.Front Pharmacol. 2022 Dec 1;13:1063246. doi: 10.3389/fphar.2022.1063246. eCollection 2022. Front Pharmacol. 2022. PMID: 36532785 Free PMC article. Review.
-
COVID-19 and Headache Medicine: A Narrative Review of Non-Steroidal Anti-Inflammatory Drug (NSAID) and Corticosteroid Use.Headache. 2020 Sep;60(8):1558-1568. doi: 10.1111/head.13903. Epub 2020 Jul 10. Headache. 2020. PMID: 32648592 Free PMC article.
-
Anti-inflammatory therapies for pericardial diseases in the COVID-19 pandemic: safety and potentiality.J Cardiovasc Med (Hagerstown). 2020 Sep;21(9):625-629. doi: 10.2459/JCM.0000000000001059. J Cardiovasc Med (Hagerstown). 2020. PMID: 32658005 Review.
Cited by
-
Unveiling the Enigma of Post-implantation Syndrome Following Aortic Dissection Repair: A Case Report.Cureus. 2023 May 12;15(5):e38928. doi: 10.7759/cureus.38928. eCollection 2023 May. Cureus. 2023. PMID: 37313086 Free PMC article.
References
-
- McKeever A. Here's what coronavirus does to the body. In: National Geographic. United States: National Geographic Partners, LLC; 2020. [Lat accessed on 2021 Mar 25]. Available from: http://www.nationalgeographic.com/science .
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous